COMETRIQTM

is now
approved

COMETRIQ (Kō-mĕ-trik) is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body.

COMETRIQ is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).

COMETRIQ is now approved by the Food and Drug Administration (FDA) and is now available.

For more information about this new product, call

1-855-253-3273